--- title: 'Research Daily Summary: What Happened on October 5, 2026' headline: Removing an embryo chromatin mark early did not speed genome activation description: Other studies engineered avian retrotransposons for targeted gene integration, recorded RNA signals as DNA barcodes and tested a bacterial-infection PET tracer in mice. url: https://thebench.bio/news/research/2026-10-05 topic: research date: '2026-10-05' covers: - '2026-10-05' date_published: '2026-10-05T12:02:23Z' date_modified: '2026-10-05T12:02:23Z' sources: 4 publisher: The Bench (thebench.bio) --- # Research Daily Summary: What Happened on October 5, 2026 **Removing an embryo chromatin mark early did not speed genome activation** Other studies engineered avian retrotransposons for targeted gene integration, recorded RNA signals as DNA barcodes and tested a bacterial-infection PET tracer in mice. ## Today in brief In mouse embryos, early removal of H3K4me3 modestly changed gene activity but did not make genome activation happen sooner or prevent embryos from reaching the blastocyst stage at rates comparable to controls. [1] Researchers also converted RNA signals into DNA barcodes to detect phage infections in bacteria and engineered avian retrotransposons that integrated genes at rates up to 60% in human primary cells. [2] [3] A fluorine-18-labeled glucose-derived tracer detected live gram-positive infections in mice, producing more than six times the signal of uninfected tissue. [4] ## Early removal of an embryo chromatin mark did not speed genome activation Researchers at EMBL Rome tracked gene activity in individual mouse embryos across nine hours of early development, using a protocol that controlled fertilization timing. [1] Embryos with similar appearances could have different RNA profiles depending on the time since fertilization. [1] As maternal RNA declined, the embryos’ own genomes became more active, including genes involved in RNA production, protein synthesis and ribosome assembly. [1] The team found that H3K4me3, a chemical modification of chromatin, was removed during genome activation and tested the effect of removing it earlier. [1] Early removal modestly affected gene activity but did not trigger earlier genome activation or prevent embryos from reaching the blastocyst stage at rates comparable to controls. [1] The findings suggest H3K4me3 is not the molecular feature that keeps the embryonic genome silent. [1] ## Also worth knowing - Researchers identified 159 avian R2 retrotransposons in 1,139 bird genomes, then engineered versions that achieved site-specific gene integration rates of up to 60% across human primary cells. [3] - Detectrons convert RNA signals into DNA barcodes in living cells, letting researchers detect specific phage infections and profile host susceptibility in pooled bacterial populations. [2] - A fluorine-18-labeled glucose-derived PET tracer detected live gram-positive infections in mouse models with more than six times the signal of uninfected tissue. It did not accumulate in aseptic inflammation. [4] ## The day in numbers - **Up to 60%**: Highest reported site-specific gene-integration rate across human primary cells using engineered avian R2 retrotransposons. [3] - **More than sixfold**: PET tracer signal at live gram-positive infection sites versus uninfected tissue in mouse models. [4] ## Also published - [This Week In Cheminformatics: Issue #041](), This Week in Cheminformatics - [Could magnetic bacteria hold the secret to longevity?](), BioTechniques - [Method for controlling brain cells with light wins Nobel](), Science News - [Microphysiological models of human gastrointestinal diseases](), Nature Biomedical Engineering - [Engineering human multi-organ tissue chip niches for drug absorption, distribution, metabolism, excretion and toxicity prediction](), Nature Biomedical Engineering ## Sources 1. [How embryos switch on their genome](), EMBL, 2026-10-05 2. [Detectrons convert transient RNA sequences into stable DNA barcodes for high-throughput analysis of RNA-dependent processes](), Nature Biotechnology, 2026-10-05 3. [Discovery and engineering of avian R2 retrotransposons for all-RNA-mediated targeted DNA integration in human cells](), Nature Biotechnology, 2026-10-05 4. [Selective PET imaging of bacterial infection using a glycosylated \18\F-fluorodeoxyglucose-derived tracer](), Nature Biomedical Engineering, 2026-10-05 --- The Bench wrote this from the reporting cited above, with a language model drafting and editing. [1]: [2]: [3]: [4]: